3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
49
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
18
Melanoma
13
Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Lung Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Thyroid Neoplasms
1
Skin Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Recurrent Squamous Cell Lung Carcinoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Motor Activity
1
Lung Squamous Cell Carcinoma Stage IV
1
Locally Advanced Melanoma
1
Locally Advanced Gastric Cancer
1
Liver Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Eunuchism
1
Esophageal Neoplasms
1
Erectile Dysfunction
1
Interventions
atezolizumab
5
avelumab
4
erdafitinib
1
enfortumab vedotin
1
darolutamide
1
Therapeutics
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Radiotherapy
1
Patient Reported Outcome Measures
1
Nivolumab
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Laparoscopy
1
Immunotherapy
1
Histocompatibility Testing
1
High-Throughput Nucleotide Sequencing
1
Hematologic Tests
1
Gemcitabine
1
Focus Groups
1
Educational Status
1
Drug Therapy
1
Defecation
1
Cytological Techniques
1
Cystoscopy
1
Cisplatin
1
Carboxylesterase
1
Blood Cell Count
1
Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Transitional Cell
×
Nivolumab
×
Clear all
NCT06421311
2025-06-05
URADJ
Bristol-Myers Squibb
Terminated
176 enrolled